Integra Lifesciences Holdings (IART) Shares Outstanding (2009 - 2026)

Integra Lifesciences Holdings has disclosed Shares Outstanding (Entity) across 18 years of filings, most recently posting $77.8 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) changed 0.18% year-over-year to $77.8 million; the TTM figure through Jun 2026 stood at $77.8 million (changed 0.18% YoY), while the FY2025 annual figure was $77.9 million, up 0.93% from the prior year.
• Shares Outstanding (Entity) came in at $77.8 million for Q2 2026 at Integra Lifesciences Holdings, roughly flat from $77.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $83.5 million in Q3 2022 to a low of $77.2 million in Q3 2024.
• Average Shares Outstanding (Entity) over 5 years is $79.4 million, with a median of $78.1 million recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) dropped 6.4% in 2023 and grew 0.94% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $81.6 million in 2022, then declined by 4.18% to $78.2 million in 2023, then decreased by 1.28% to $77.2 million in 2024, then increased by 0.93% to $77.9 million in 2025, then dropped by 0.21% to $77.8 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $77.8 million in Q2 2026, $77.8 million in Q1 2026, and $77.9 million in Q4 2025.